The Vanguard Group, Inc. recently announced the acquisition of new stake in Exantas Capital Corp. (NYSE:XAN). The institutional investor has increased its shareholding in the Real Estate company by 62.40% to 2.73 million shares with purchase of 1.05 million shares. This fresh investment now brings its stake to 8.52% valued currently at $7.23 million. In addition, D. E. Shaw & Co. LP raised its holdings by 1.16 million to 1.63 million shares. And Northern Trust Investments, Inc.(. has lifted its position by 1.31% or 19119.0 shares – to 1.48 million shares.
With over 0.58 million Exantas Capital Corp. (XAN) shares trading Tuesday and a closing price of $2.36 on the day, the dollar volume was approximately $1.38 million. The shares have shown a negative weekly performance of -0.84% and its price on 07/28/20 gained nearly 4.89%. Currently, there are 31.63M common shares owned by the public and among those 31.04M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 2 analysts who have offered their price forecasts for XAN have a consensus price objective of $4.00. The analysts have set the share’s price value over the next 12 months at a high of $4.00 and a low of $4.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Exantas Capital Corp. stock is 2.50 for the next 12 months. The average price target is 41.0% above its last price level and an upside to the estimated low will see the stock gain 41.0% over that period. But an upside of 41.0% will see the stock hit the forecast high price target while mean target price for the stock is $4.00.
Insiders at the company have transacted a total of 24 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 24 of these insider trades were purchases, accounting for 175,892 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Exantas Capital Corp. are Vanguard Total Stock Market Index, Salient Select Income Fund, and Northern Small Cap Value Fund. Vanguard Total Stock Market Index owns 1.5 million shares of the company’s stock, all valued at over $3.97 million. The company sold -0.34 million shares recently to bring their total holdings to about 4.67% of the shares outstanding. Northern Small Cap Value Fund now owns shares totaling to 1.63% of the shares outstanding.
Shares of Exantas Capital Corp. (NYSE: XAN) opened at $2.27, up $0.02 from a prior closing price of $2.25. However, the script later closed the day at $2.36, up 4.89%. The company’s stock has a 5-day price change of -0.84% and -7.09% over the past three months. XAN shares are trading -80.02% year to date (YTD), with the 12-month market performance down to -79.10% lower. It has a 12-month low price of $0.95 and touched a high of $12.51 over the same period. Currently, 0.58 million shares have been traded, compared to an average intraday trading volume of 1.69 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.56%, -6.42%, and -68.48% respectively.
Institutional ownership of Exantas Capital Corp. (NYSE: XAN) shares accounts for 70.90% of the company’s 31.63M shares outstanding. Mutual fund holders own 5.84%, while other institutional holders and individual stakeholders account for 55.02% and 20.10% respectively.
It has a market capitalization of $73.47M and a beta (3y monthly) value of 1.38. The earnings-per-share (ttm) stands at -$5.66. The company has a debt-to-equity ratio at 5.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.35% over the week and 8.31% over the month.
Analysts forecast that Exantas Capital Corp. (XAN) will achieve an EPS of $0.18 for the current quarter, $0.21 for the next quarter and $0.49 for 2021. The lowest estimate earnings-per-share for the quarter is $0.06 while analysts give the company a high EPS estimate of $0.3. Comparatively, EPS for the current quarter was $0.28 a year ago. Earnings per share for the fiscal year are expected to increase by 274.10%, and -44.63% over the next financial year. EPS should grow at an annualized rate of 5.00% over the next five years, compared to -8.60% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 2 brokerage firm advisors rate Exantas Capital Corp. (XAN) as a “Moderate Buy” at a consensus score of 2.50. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 1 of the 2 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the XAN, a number of firms have released research notes about the stock. Raymond James stated their Mkt Perform rating for the stock in a research note on April 13, 2020, with the firm’s price target at. BTIG Research coverage for the Exantas Capital Corp. (XAN) stock in a research note released on October 09, 2018 offered a Buy rating with a price target of.